Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Down-regulation of SENP1 Expression Increases Apoptosis of Burkitt Lymphoma Cells

  • Huang, Bin-Bin (Department of Hematology, Tongji Hospital of Tongji University) ;
  • Gao, Qing-Mei (Department of Hematology, Tongji Hospital of Tongji University) ;
  • Liang, Wei (Department of Hematology, Tongji Hospital of Tongji University) ;
  • Xiu, Bing (Department of Hematology, Tongji Hospital of Tongji University) ;
  • Zhang, Wen-Jun (Department of Hematology, Tongji Hospital of Tongji University) ;
  • Liang, Ai-Bin (Department of Hematology, Tongji Hospital of Tongji University)
  • Published : 2012.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To investigate the effect of down-regulation of Sentrin/SUMO-specific protease 1 (SENP1) expression on the apoptosis of human Burkitt lymphoma cells (Daudi cells) and potential mechanisms. Methods: Short hairpin RNA (shRNA) targeting SENP1 was designed and synthesized and then cloned into a lentiviral vector. A lentiviral packaging plasmid was used to transfect Daudi cells (sh-SENP1-Daudi group). Daudi cells without transfection (Daudi group) and Daudi cells transfected with blank plasmid (sh-NC-Daudi group) served as control groups. Flow cytometry was performed to screen GFP positive cells and semiquantitative PCR and Western blot assays were employed to detect the inference efficiency. The morphology of cells was observed under a microscope before and after transfection. Fluorescence quantitative PCR and Western blot assays were conducted to measure the mRNA and protein expression of apoptosis related molecules (caspase-3, 8 and 9). After treatment with $COCl_2$ for 24 h, the mRNA and protein expression of hypoxia inducible factor -$1{\alpha}$ (HIF-$1{\alpha}$) was determined. Results: Sequencing showed the expression vectors of shRNA targeting SENP1 to be successfully constructed. Following screening of GFP positive cells by FCM, semiqualitative PCR showed the interference efficiency was $79.2{\pm}0.026%$. At 48 h after transfection, the Daudi cells became shrunken, had irregular edges and presented apoptotic bodies. Western blot assay revealed increase in expression of caspase-3, 8 and 9 with prolongation of transfection (P<0.05). Following hypoxia treatment, mRNA expression of HIF-$1{\alpha}$ remained unchanged in three groups (P>0.05) but the protein expression of HIF-$1{\alpha}$ markedly increased (P<0.05). However, in the sh-SENP1-Daudi group, the protein expression of HIF-$1{\alpha}$ remained unchanged Conclusion: SENP1-shRNA can efficiently inhibit SENP1 expression in Daudi cells. SENP1 inhibition may promote cell apoptosis. These findings suggest that SENP1 may serve as an important target in the gene therapy of Burkitts lymphoma.

Keywords

References

  1. Bae SH, Jeonga JW, Park JA, et al (2004). Sumoylation increases HIF-$1{\alpha}stability$ and its transcriptional activity. Biochem Biophys Res Commun, 324, 394-400. https://doi.org/10.1016/j.bbrc.2004.09.068
  2. Barliya T, Mandel M, Livnat T, et al (2011). Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy. PLoS One, 6, e22849 https://doi.org/10.1371/journal.pone.0022849
  3. Bawa-Khalfe T, Cheng J, Wang Z, Yeh ET (2007). Induction of the SUMO-specific proteasel transcription by the androgen receptor in prostate cancer cells. J Biol Chem, 282, 37341-9. https://doi.org/10.1074/jbc.M706978200
  4. Chavez JC, LaManna JC (2002). Activation of hypoxia-induced factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci, 2, 8922-31.
  5. Cheng J, Kang XL, Zhang S, et al (2007). SUMO-Specific protease l is essential for stabilization of HIFl alpha during hypoxia. Cell, 131, 584-95. https://doi.org/10.1016/j.cell.2007.08.045
  6. Du J, Xu R, Hu Z, Tian Y, et al (2011). PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-$1{\alpha}$ expression in MCF-7 breast cancer cells. PLoS One, 6, e25213. https://doi.org/10.1371/journal.pone.0025213
  7. El Guerrab A, Zegrour R, Nemlin CC et al (2011). Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer. PloS One, 6, e25080 https://doi.org/10.1371/journal.pone.0025080
  8. Freise C, Ruehl M, Erben U, et al (2011). A hepatoprotective Lindera obtusiloba extract suppresses growth and attenuates insulin like growth factor-1 receptor signaling and NFkappaB activity in human liver cancer cell lines. BMC Complement Altern Med, 11, 39. https://doi.org/10.1186/1472-6882-11-39
  9. Jean M (2004). How cells endure low oxygen. Science, 303, 1454-6. https://doi.org/10.1126/science.303.5663.1454
  10. Liao HY, Wang GP, Gu LJ, et al (2012). HIF-$1\alpha$ siRNA and cisplatin in combination suppresstumor growth in a nude mice model of esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 13, 473-7. https://doi.org/10.7314/APJCP.2012.13.2.473
  11. Resar JR, Roguin A, Voner J, et al (2005). Hypoxia-inducible factor-$1{\alpha}polymorphism$ and coronary collaterals in patients with is chemic heart disease. Chest, 128, 787-91. https://doi.org/10.1378/chest.128.2.787
  12. Sapra P, Kraft P, Pastorino F et al (2011). Potent and sustained inhibition of HIF-$1{\alpha}$ and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects. Angiogenesis, 14, 245-53 https://doi.org/10.1007/s10456-011-9209-1
  13. Shalizi A, Gaudilliere B, Yuan ZQ et al (2006). A calciumregulated MEF2 sumoylation switch controls postsynaptic differentiation. Science, 311, 1012-7. https://doi.org/10.1126/science.1122513
  14. Shen ZX, Zhu XZ (2003). Malignant lymphoma. Beijing: People's Health Publishing House, 532-45.
  15. Song T, Zhang X, Wang C, et al (2011). MiR-138 suppresses expression of hypoxia-inducible factor $1\alpha$ (HIF-$1\alpha$) in clear cell renal cell carcinoma 786-O cells. Asian Pac J Cancer Prev, 12, 1307-11.
  16. Wang HR, Gu CH, Zhong JH, et al (2006). Combined use of flow cytometry and G418 to screen the recombinant plasmid transfected cells. J Diagn Concep Pract, 5, 52-5.
  17. Yates KE, Korbel GA, Shtutman M, et al (2008). Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts. Aging Cell, 7, 609-21. https://doi.org/10.1111/j.1474-9726.2008.00411.x
  18. Yeh ET, Gong L, Kamitani T (2000). Ubiquitin-like proteins: new wines in new bottles. Gene, 248, 1-14 . https://doi.org/10.1016/S0378-1119(00)00139-6
  19. Zhou W, Dosey TL, Biechele T, et al (2011). Assessment of hypoxia inducible factor levels in cancer cell lines upon hypoxic induction using a novel reporter construct. PLoS One, 6, e27460. https://doi.org/10.1371/journal.pone.0027460

Cited by

  1. SUMO-specific proteases/isopeptidases: SENPs and beyond vol.15, pp.7, 2014, https://doi.org/10.1186/s13059-014-0422-2
  2. shRNA-mediated Bmi-1 silencing sensitizes multiple myeloma cells to bortezomib vol.34, pp.2, 2014, https://doi.org/10.3892/ijmm.2014.1798
  3. SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9 vol.35, pp.12, 2014, https://doi.org/10.1007/s13277-014-2598-1
  4. Sumoylation of hypoxia inducible factor-1α and its significance in cancer vol.57, pp.7, 2014, https://doi.org/10.1007/s11427-014-4685-3
  5. Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells vol.36, pp.4, 2016, https://doi.org/10.3892/or.2016.5036
  6. SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma vol.37, pp.6, 2016, https://doi.org/10.1007/s13277-015-4406-y
  7. Inhibition of p53 deSUMOylation Exacerbates Puromycin Aminonucleoside-Induced Apoptosis in Podocytes vol.15, pp.11, 2014, https://doi.org/10.3390/ijms151121314
  8. Deficiency of SUMO-specific protease 1 induces arsenic trioxide-mediated apoptosis by regulating XBP1 activity in human acute promyelocytic leukemia vol.12, pp.5, 2016, https://doi.org/10.3892/ol.2016.5162